sulpiride has been researched along with Torsade de Pointes in 15 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulpiride-induced torsades de pointes is rare." | 5.35 | Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning. ( Chang, JH; Fang, CC; Weng, TI, 2009) |
| "There was 1 case of torsade de pointes in a thioridazine overdose." | 1.42 | Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram. ( Berling, I; Isbister, GK, 2015) |
| "As part of the FP7 ARITMO (Arrhythmogenic Potential of Drugs) project, we explored the publicly available US FDA Adverse Event Reporting System (FAERS) database to detect signals of torsadogenicity for antipsychotics (APs)." | 1.39 | Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database. ( Behr, ER; De Ponti, F; Koci, A; Moretti, U; Poluzzi, E; Raschi, E; Spina, E; Sturkenboom, M, 2013) |
| "Sulpiride-induced torsades de pointes is rare." | 1.35 | Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning. ( Chang, JH; Fang, CC; Weng, TI, 2009) |
| "Although clinical trials of the antipsychotic amisulpride revealed no cardiac adverse effects, four patients with severe cardiac toxicity after overdose were reported to Australian poisons information centres in 2004-2005." | 1.33 | Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. ( Daly, F; Gosselin, S; Hackett, LP; Haider, T; Isbister, GK; John, S; Murray, L; O'Mullane, P, 2006) |
| "Torsades de pointes were treated with potassium chloride infusion and pace maker stimulation." | 1.28 | [Torsades de pointes during sultopride poisoning]. ( Aymes, C; Delille, F; Harry, P; Hass, C; Montaz, L; Simonin, D; Turcant, A; Varache, N, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poluzzi, E | 1 |
| Raschi, E | 1 |
| Koci, A | 1 |
| Moretti, U | 1 |
| Spina, E | 1 |
| Behr, ER | 1 |
| Sturkenboom, M | 1 |
| De Ponti, F | 1 |
| Berling, I | 1 |
| Isbister, GK | 4 |
| Chung, AK | 1 |
| Chua, SE | 1 |
| Chang, JH | 1 |
| Weng, TI | 1 |
| Fang, CC | 1 |
| Balit, CR | 1 |
| Macleod, D | 1 |
| Duffull, SB | 2 |
| Joy, JP | 1 |
| Coulter, CV | 1 |
| Teng, PR | 1 |
| Shen, TY | 1 |
| Lai, TJ | 1 |
| Sugiyama, A | 2 |
| Satoh, Y | 1 |
| Shiina, H | 1 |
| Takeda, S | 1 |
| Hashimoto, K | 1 |
| Murray, L | 1 |
| John, S | 1 |
| Hackett, LP | 1 |
| Haider, T | 1 |
| O'Mullane, P | 1 |
| Gosselin, S | 1 |
| Daly, F | 1 |
| Huang, BH | 1 |
| Hsia, CP | 1 |
| Chen, CY | 1 |
| Kondou, N | 1 |
| Hiasa, Y | 1 |
| Kishi, K | 1 |
| Fujinaga, H | 1 |
| Ohishi, Y | 1 |
| Ohtani, R | 1 |
| Wada, T | 1 |
| Aihara, T | 1 |
| Züchner, H | 1 |
| Lande, G | 1 |
| Drouin, E | 1 |
| Gauthier, C | 1 |
| Chevallier, JC | 1 |
| Godin, JF | 1 |
| Chiffoleau, A | 1 |
| Le Marec, H | 1 |
| Montaz, L | 1 |
| Varache, N | 1 |
| Harry, P | 1 |
| Aymes, C | 1 |
| Turcant, A | 1 |
| Delille, F | 1 |
| Simonin, D | 1 |
| Hass, C | 1 |
1 review available for sulpiride and Torsade de Pointes
| Article | Year |
|---|---|
[Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Antipsychotic Agents; Antitubercular Agents; Cat | 2003 |
14 other studies available for sulpiride and Torsade de Pointes
| Article | Year |
|---|---|
Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.
Topics: Adverse Drug Reaction Reporting Systems; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Be | 2013 |
Prolonged QT Risk Assessment in Antipsychotic Overdose Using the QT Nomogram.
Topics: Adolescent; Adult; Aged; Amisulpride; Antipsychotic Agents; Drug Overdose; Electrocardiography; Fema | 2015 |
Torsade de pointes associated with low-dose amisulpride: a case report.
Topics: Amisulpride; Antipsychotic Agents; Female; Humans; Middle Aged; Sulpiride; Torsades de Pointes | 2010 |
Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.
Topics: Dopamine Antagonists; Female; Humans; Lidocaine; Long QT Syndrome; Magnesium Sulfate; Sulpiride; Tor | 2009 |
Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
Topics: Adult; Amisulpride; Antipsychotic Agents; Bradycardia; Cohort Studies; Drug Overdose; Electrocardiog | 2010 |
Prediction of torsade de pointes from the QT interval: analysis of a case series of amisulpride overdoses.
Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Overdos | 2011 |
Sulpiride-associated torsade de pointes in a woman with bipolar disorder.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Electrocardiogr | 2012 |
Torsadegenic action of the antipsychotic drug sulpiride assessed using in vivo canine models.
Topics: Action Potentials; Aged; Aged, 80 and over; Animals; Antipsychotic Agents; Dogs; Dopamine Antagonist | 2002 |
Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes.
Topics: Adult; Amisulpride; Antipsychotic Agents; Arrhythmias, Cardiac; Drug Overdose; Electrocardiography; | 2006 |
Sulpiride induced torsade de pointes.
Topics: Aged; Antipsychotic Agents; Bipolar Disorder; Coronary Angiography; Dose-Response Relationship, Drug | 2007 |
[A case of life-threatening ventricular arrhythmias probably due to psychotropic drugs].
Topics: Electrocardiography, Ambulatory; Humans; Male; Middle Aged; Promethazine; Sulpiride; Tachycardia, Ve | 1993 |
[QT prolongation and torsade de pointes--tachycardia in therapy with maprotiline].
Topics: Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain Damage, Chronic; | 2002 |
[Arrhythmogenic effects of sultopride chlorhydrate: clinical and cellular electrophysiological correlation].
Topics: Action Potentials; Amisulpride; Animals; Antipsychotic Agents; Electrocardiography; Female; Humans; | 1992 |
[Torsades de pointes during sultopride poisoning].
Topics: Adult; Amisulpride; Antipsychotic Agents; Humans; Male; Potassium Chloride; Sulpiride; Torsades de P | 1992 |